{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:54Z","timestamp":1791999174231,"version":"4.4.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200900045C"],"award-info":[{"award-number":["HHSN272200900045C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01836","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T11:27:27Z","timestamp":1598873247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["A Systematic, Unbiased Mapping of CD8+ and CD4+ T Cell Epitopes in Yellow Fever Vaccinees"],"prefix":"10.3389","volume":"11","author":[{"given":"Anette","family":"Stryhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kongsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Nors","family":"Harndahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"\u00d8sterbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Thybo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Bagge","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Pravsgaard","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Randrup Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soren","family":"Buus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.immunol.17.1.51","article-title":"Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses","volume":"17","author":"Yewdell","year":"1999","journal-title":"Annu Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0952-7915(99)80035-1","article-title":"Description and prediction of peptide-MHC binding: the human MHC project","volume":"11","author":"Buus","year":"1999","journal-title":"Curr Opin Immunol."},{"key":"B4","first-page":"477","article-title":"Identifying cytotoxic T cell epitopes from genomic and proteomic information: The human MHC project","volume":"2","author":"Lauemoller","year":"2000","journal-title":"Rev Immunogenet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00251-019-01137-6","article-title":"The immune epitope database and analysis resource program 2003-2018: reflections and outlook","volume":"72","author":"Martini","year":"2020","journal-title":"Immunogenetics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.immuni.2017.07.010","article-title":"A case for a human immuno-peptidome project consortium","volume":"47","author":"Caron","year":"2017","journal-title":"Immunity."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1700252","DOI":"10.1002\/pmic.201700252","article-title":"Computational tools for the identification and interpretation of sequence motifs in immunopeptidomes","volume":"18","author":"Alvarez","year":"2018","journal-title":"Proteomics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nbt.3800","volume":"35","year":"2017","journal-title":"Nat Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/sj.leu.2404787","article-title":"Identification of T-cell epitopes for cancer immunotherapy","volume":"21","author":"Kessler","year":"2007","journal-title":"Leukemia."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3389\/fimmu.2017.01367","article-title":"Bassani-sternberg: \u2018hotspots' of antigen presentation revealed by human leukocyte antigen ligandomics for neoantigen prioritization","volume":"8","author":"Muller","year":"2017","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13073-019-0666-2","article-title":"Best practices for bioinformatic characterization of neoantigens for clinical utility","volume":"11","author":"Richters","year":"2019","journal-title":"Genome Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/bioinformatics\/btx820","article-title":"An automated benchmarking platform for MHC class II binding prediction methods","volume":"34","author":"Andreatta","year":"2018","journal-title":"Bioinformatics."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41587-019-0289-6","article-title":"Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes","volume":"37","author":"Racle","year":"2019","journal-title":"Nat Biotechnol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1074\/mcp.TIR119.001658","article-title":"NNAlign_MA; MHC peptidome deconvolution for accurate MHC binding motif characterization and improved T-cell epitope predictions","volume":"18","author":"Alvarez","year":"2019","journal-title":"Mol Cell Proteomics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13073-018-0594-6","article-title":"Footprints of antigen processing boost MHC class II natural ligand predictions","volume":"10","author":"Barra","year":"2018","journal-title":"Genome Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-016-0288-x","article-title":"NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets","volume":"8","author":"Nielsen","year":"2016","journal-title":"Genome Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.4049\/jimmunol.178.12.7890","article-title":"A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection","volume":"178","author":"Assarsson","year":"2007","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3109\/14767058.2015.1039977","article-title":"Why 99% may not be as good as you think it is: limitations of screening for rare diseases","volume":"29","author":"Lutgendorf","year":"2016","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature."},{"key":"B20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature."},{"key":"B22","article-title":"Yellow fever vaccine","volume-title":"Vaccines","author":"Monath","year":"2012"},{"key":"B23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1001638","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow fever expert: yellow fever in africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data","volume":"11","author":"Garske","year":"2014","journal-title":"PLoS Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity."},{"key":"B26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41598-017-00798-1","article-title":"Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination","volume":"7","author":"Kongsgaard","year":"2017","journal-title":"Sci Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1084\/jem.176.5.1453","article-title":"A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E","volume":"176","author":"Traversari","year":"1992","journal-title":"J Exp Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2174\/1566524013363447","article-title":"Linking genomics to immunotherapy by reverse immunology\u2013'immunomics' in the new millennium","volume":"1","author":"Maecker","year":"2001","journal-title":"Curr Mol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.4049\/jimmunol.1202351","article-title":"Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach","volume":"190","author":"Hombrink","year":"2013","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1093\/nar\/17.10.3989","article-title":"Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines","volume":"17","author":"Dupuy","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0117160","DOI":"10.1371\/journal.pone.0117160","article-title":"Abacavir-reactive memory T cells are present in drug naive individuals","volume":"10","author":"Lucas","year":"2015","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e26494","DOI":"10.1371\/journal.pone.0026494","article-title":"Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength","volume":"6","author":"Lund","year":"2011","journal-title":"PLoS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/eji.201747082","article-title":"Fuertes marraco: T cell receptor alpha variable 12-2 bias in the immunodominant response to yellow fever virus","volume":"48","author":"Bovay","year":"2018","journal-title":"Eur J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1371\/journal.pone.0000796","article-title":"NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence","volume":"2","author":"Nielsen","year":"2007","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-mhc class i interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cels.2018.05.014","article-title":"MHCflurry: open-source class I MHC binding affinity prediction","volume":"7","author":"O'Donnell","year":"2018","journal-title":"Cell Syst."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1005725","DOI":"10.1371\/journal.pcbi.1005725","article-title":"Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity","volume":"13","author":"Bassani-Sternberg","year":"2017","journal-title":"PLoS Comput Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4049\/jimmunol.1600582","article-title":"Pan-Specific prediction of peptide-MHC class I complex stability, a correlate of T cell immunogenicity","volume":"197","author":"Rasmussen","year":"2016","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/bib\/bbz051","article-title":"A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction","volume":"21","author":"Mei","year":"2019","journal-title":"Brief Bioinform."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-5-2","article-title":"Functional recombinant MHC class II molecules and high-throughput peptide-binding assays","volume":"5","author":"Justesen","year":"2009","journal-title":"Immunome Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.bbmt.2014.11.001","article-title":"Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation","volume":"21","author":"Zilberberg","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B44","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.183.3.725","article-title":"Human tumor antigens recognized by T lymphocytes","volume":"183","author":"Boon","year":"1996","journal-title":"J Exp Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu Rev Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.4049\/jimmunol.175.11.7550","article-title":"Diversity in the acute CD8 T cell response to vaccinia virus in humans","volume":"175","author":"Jing","year":"2005","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"E7578","DOI":"10.1073\/pnas.1806200115","article-title":"Analysis of CD8(+) T cell response during the 2013-2016 Ebola epidemic in West Africa","volume":"115","author":"Sakabe","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.4049\/jimmunol.1502366","article-title":"Extensive CD4 and CD8 T cell cross-reactivity between alphaherpesviruses","volume":"196","author":"Jing","year":"2016","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"12794","DOI":"10.1128\/JVI.01160-13","article-title":"Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins","volume":"87","author":"James","year":"2013","journal-title":"J Virol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e58309","DOI":"10.1371\/journal.pone.0058309","article-title":"A broad profile of co-dominant epitopes shapes the peripheral mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis","volume":"8","author":"Axelsson-Robertson","year":"2013","journal-title":"PLoS ONE."},{"key":"B51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0065-230X(06)95006-4","article-title":"Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines","volume":"95","author":"Chen","year":"2006","journal-title":"Adv Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.4049\/jimmunol.1400854","article-title":"CD8+ TCR Bias and immunodominance in HIV-1 Infection","volume":"194","author":"Kloverpris","year":"2015","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev.genom.7.080505.115726","article-title":"The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense","volume":"7","author":"Bashirova","year":"2006","journal-title":"Annu Rev Genomics Hum Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/eji.1830070816","article-title":"Molecular structure of human histocompatibility antigens: the HLA-C series","volume":"7","author":"Snary","year":"1977","journal-title":"Eur J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1084\/jem.176.4.937","article-title":"Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C","volume":"176","author":"Zemmour","year":"1992","journal-title":"J Exp Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.1403234","article-title":"Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells","volume":"194","author":"Apps","year":"2015","journal-title":"J Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1182\/blood-2014-09-599969","article-title":"International histocompatibility working group in hematopoietic cell: HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation","volume":"124","author":"Petersdorf","year":"2014","journal-title":"Blood."},{"key":"B58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.1232685","article-title":"Influence of HLA-C expression level on HIV control","volume":"340","author":"Apps","year":"2013","journal-title":"Science."},{"key":"B59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1128\/JVI.03047-12","article-title":"CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence","volume":"87","author":"Jing","year":"2013","journal-title":"J Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"Greenbaum","year":"2011","journal-title":"Immunogenetics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00251-013-0684-y","article-title":"A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population","volume":"65","author":"McKinney","year":"2013","journal-title":"Immunogenetics."},{"key":"B63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00251-014-0819-9","article-title":"Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires","volume":"67","author":"Bergseng","year":"2015","journal-title":"Immunogenetics."},{"key":"B64","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/328395a0","article-title":"Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells","volume":"328","author":"Sette","year":"1987","journal-title":"Nature."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1074\/jbc.270.3.1088","article-title":"Major histocompatibility class I molecules can present cryptic translation products to T-cells","volume":"270","author":"Shastri","year":"1995","journal-title":"J Biol Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1016\/j.vaccine.2006.12.038","article-title":"CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, HLA-wide screening","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1678","DOI":"10.1371\/journal.pone.0001678","article-title":"One-pot, mix-and-read peptide-MHC tetramers","volume":"3","author":"Leisner","year":"2008","journal-title":"PLoS ONE."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e1000107","DOI":"10.1371\/journal.pcbi.1000107","article-title":"Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan","volume":"4","author":"Nielsen","year":"2008","journal-title":"PLoS Comput Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jim.2010.10.012","article-title":"Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay","volume":"374","author":"Harndahl","year":"2011","journal-title":"J Immunol Methods."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T11:27:31Z","timestamp":1598873251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2020.01836"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01836","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.28.012468","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"article-number":"1836"}}